Olfactory identification deficits and increased mortality in the community
- PMID: 26031760
- PMCID: PMC4546561
- DOI: 10.1002/ana.24447
Olfactory identification deficits and increased mortality in the community
Abstract
Objective: To examine the association between odor identification deficits and future mortality in a multiethnic community cohort of older adults.
Methods: Participants were evaluated with the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Follow-up occurred at 2-year intervals with information on death obtained from informant interviews and the National Death Index.
Results: During follow-up (mean = 4.1 years, standard deviation = 2.6), 349 of 1,169 (29.9%) participants died. Participants who died were more likely to be older (p < 0.001), be male (p < 0.001), have lower UPSIT scores (p < 0.001), and have a diagnosis of dementia (p < 0.001). In a Cox model, the association between lower UPSIT score and mortality (hazard ratio [HR] = 1.07 per point interval, 95% confidence interval [CI] = 1.05-1.08, p < 0.001) persisted after controlling for age, gender, education, ethnicity, language, modified Charlson medical comorbidity index, dementia, depression, alcohol abuse, head injury, smoking, body mass index, and vision and hearing impairment (HR = 1.05, 95% CI = 1.03-1.07, p < 0.001). Compared to the fourth quartile with the highest UPSIT scores, HRs for mortality for the first, second, and third quartiles of UPSIT scores were 3.81 (95% CI = 2.71-5.34), 1.75 (95% CI = 1.23-2.50), and 1.58 (95% CI = 1.09-2.30), respectively. Participant mortality rate was 45% in the lowest quartile of UPSIT scores (anosmia) and 18% in the highest quartile of UPSIT scores.
Interpretation: Impaired odor identification, particularly in the anosmic range, is associated with increased mortality in older adults even after controlling for dementia and medical comorbidity.
© 2015 American Neurological Association.
Conflict of interest statement
D.P. Devanand has received consulting fees from AbbVie and Lundbeck. Richard Doty is President and major shareholder of Sensonics, Inc., a manufacturer and distributor of tests of taste and smell, including the UPSIT. Richard Doty has received publishing royalties from Cambridge University Press and Johns Hopkins University Press, and an honorarium from the University of Florida and lodging reimbursement as Chairperson of the Other Non-Motor Features of Parkinson’s Disease working group of the Parkinson Study Group. He has received consulting fees from Pfizer, Inc., Acorda Therapeutics and several law offices. There are no other conflicts of interest.
Figures
Similar articles
-
Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.Neurology. 2015 Jan 13;84(2):182-9. doi: 10.1212/WNL.0000000000001132. Epub 2014 Dec 3. Neurology. 2015. PMID: 25471394 Free PMC article.
-
Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly.Mov Disord. 2008 Mar 15;23(4):524-30. doi: 10.1002/mds.21777. Mov Disord. 2008. PMID: 18098296 Free PMC article.
-
Application of the University Of Pennsylvania Smell Identification Test (traditional Chinese version) for detecting olfactory deficits in early Parkinson's disease in a Taiwanese cohort.J Parkinsons Dis. 2014;4(2):175-80. doi: 10.3233/JPD-130309. J Parkinsons Dis. 2014. PMID: 24796234
-
Long-Term Test-Retest Reliability of the UPSIT in Cognitively Intact Older Adults.Chem Senses. 2019 Jul 17;44(6):365-369. doi: 10.1093/chemse/bjz025. Chem Senses. 2019. PMID: 31111142 Free PMC article.
-
Smell Loss Predicts Mortality Risk Regardless of Dementia Conversion.J Am Geriatr Soc. 2017 Jun;65(6):1238-1243. doi: 10.1111/jgs.14770. Epub 2017 Mar 22. J Am Geriatr Soc. 2017. PMID: 28326534
Cited by
-
Inflammation and olfactory loss are associated with at least 139 medical conditions.Front Mol Neurosci. 2024 Oct 11;17:1455418. doi: 10.3389/fnmol.2024.1455418. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39464255 Free PMC article.
-
A Review of the Role of Estrogens in Olfaction, Sleep and Glymphatic Functionality in Relation to Sex Disparity in Alzheimer's Disease.Am J Alzheimers Dis Other Demen. 2024 Jan-Dec;39:15333175241272025. doi: 10.1177/15333175241272025. Am J Alzheimers Dis Other Demen. 2024. PMID: 39116421 Free PMC article. Review.
-
High prevalence of long-term olfactory disorders in healthcare workers after COVID-19: A case-control study.PLoS One. 2024 Jul 1;19(7):e0306290. doi: 10.1371/journal.pone.0306290. eCollection 2024. PLoS One. 2024. PMID: 38950019 Free PMC article.
-
Effects of genetics on odor perception: Can a quick smell test effectively screen everyone?Chem Senses. 2024 Jan 1;49:bjae025. doi: 10.1093/chemse/bjae025. Chem Senses. 2024. PMID: 38877790
-
Recent Advances and Future Perspectives in the E-Nose Technologies Addressed to the Wine Industry.Sensors (Basel). 2024 Apr 4;24(7):2293. doi: 10.3390/s24072293. Sensors (Basel). 2024. PMID: 38610504 Free PMC article. Review.
References
-
- Hyman BT, Arriagada PV, Van Hoesen GW. Pathologic changes in the olfactory system in aging and Alzheimer’s disease. Ann N Y Acad Sci. 1991;640:14–19. - PubMed
-
- Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 2006;21:2062–2067. - PubMed
-
- Doty RL, Shaman P, Applebaum SL, et al. Smell identification ability: changes with age. Science. 1984;226:1441–1443. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
